[What can be expected from enzyme inhibitors in rheumatology?].
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002918:Chymotrypsin / Q000627:therapeutic use*; D005341:Fibrinolysin / Q000627:therapeutic use*; D006801:Humans; D007263:Infusions, Parenteral; D007270:Injections, Intra-Articular; D007592:Joint Diseases / Q000188:drug therapy*; D010455:Peptides / Q000627:therapeutic use*; D011480:Protease Inhibitors; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012585:Sciatica / Q000188:drug therapy*; D014357:Trypsin / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D010455:Peptides; D011480:Protease Inhibitors; D002918:Chymotrypsin; D014357:Trypsin; D005341:Fibrinolysin
Qu'attendre des inhibiteurs d'enzymes en rhumatologie.